2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Carboxypeptidase A2 Protein (Entity type)	Ki
2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Collagenase 3 Protein (Entity type)	Ki
2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Carboxypeptidase A1 Protein (Entity type)	Ki
2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Stromelysin-2 Protein (Entity type)	Ki
2-((1E,3Z,5Z)-3-(4-(2-((2-Carboxy-4-phenylbutyl)-(hydroxy)phosphoryl)-5-(4-hydroxybenzyl)-4,7,16,29-tetraoxo-9,12,19,22,25-pentaoxa-3,6,15,28-tetraazahentriacontan-31-yl)-phenyl)-5-(1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-6,8-disulfo-3-(4-sulfobutyl)-1H-benzo[e]indol-3-ium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Carboxypeptidase A4 Protein (Entity type)	Ki